Palivizumab injection is used to prevent serious lung infection in children and babies caused by respiratory syncytial virus ...
Jason McLellan, professor in the Department of Molecular Biosciences and Robert A. Welch Chair in Chemistry at UT, will be ...
InvisiShield Technologies Ltd., a biotechnology company revolutionizing respiratory viral protection with engineered intranasal antibodies that extend beyond the capabilities of vaccines, today ...
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...
McLellan, who will be inducted in Washington, D.C. on May 8, is among the youngest new inductees in hall of fame history.
Scanning electron micrograph of human respiratory syncytial virus (RSV) virions (colorized blue) and tagged with antibodies (colorized yellow) against the virus’ fusion protein — the target of ...
Testing was performed using BinaxNOW RSV immunochromatographic assays to detect RSV fusion protein antigen in nasopharyngeal swabs (93% sensitivity, 93% specificity, Alere Scarborough Inc ...
The two vaccines induce the immune system to target a critical protein on the surface of RSV, the F protein, in its pre-infection form, known as pre-fusion F. High levels of antibodies against pre ...